Nijziel MR - Search Results

1

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.

de Vries S, Schaapveld M, Janus CPM, Daniëls LA, Petersen EJ, van der Maazen RWM, Zijlstra JM, Beijert M, Nijziel MR, Verschueren KMS, Kremer LCM, van Eggermond AM, Lugtenburg PJ, Krol ADG, Roesink JM, Plattel WJ, van Spronsen DJ, van Imhoff GW, de Boer JP, Aleman BMP, van Leeuwen FE. de Vries S, et al. Among authors: nijziel mr. J Natl Cancer Inst. 2021 Jun 1;113(6):760-769. doi: 10.1093/jnci/djaa194. J Natl Cancer Inst. 2021. PMID: 33351090 Free PMC article.

2

Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting.

van de Schans SA, Steyerberg EW, Nijziel MR, Creemers GJ, Janssen-Heijnen ML, van Spronsen DJ. van de Schans SA, et al. Among authors: nijziel mr. Ann Oncol. 2009 Oct;20(10):1697-702. doi: 10.1093/annonc/mdp053. Epub 2009 Jun 23. Ann Oncol. 2009. PMID: 19549712 Free article.

3

Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting.

van de Schans SA, Janssen-Heijnen ML, Nijziel MR, Steyerberg EW, van Spronsen DJ. van de Schans SA, et al. Among authors: nijziel mr. Haematologica. 2010 Sep;95(9):1503-9. doi: 10.3324/haematol.2009.021113. Epub 2010 May 21. Haematologica. 2010. PMID: 20494934 Free PMC article.

4

The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry.

Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JW, van de Poll-Franse LV. Oerlemans S, et al. Among authors: nijziel mr. J Cancer Surviv. 2014 Dec;8(4):555-64. doi: 10.1007/s11764-014-0367-1. Epub 2014 May 13. J Cancer Surviv. 2014. PMID: 24820429

5

Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.

Ekels A, van de Poll-Franse LV, Posthuma EFM, Kieffer J, Issa DE, Koster A, Nijziel MR, Pruijt JHFM, Stevens WBC, Tick LW, Oerlemans S. Ekels A, et al. Among authors: nijziel mr. Br J Haematol. 2022 Jun;197(5):590-601. doi: 10.1111/bjh.18139. Epub 2022 Apr 2. Br J Haematol. 2022. PMID: 35365860

6

Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.

Krul IM, Boekel NB, Kramer I, Janus CPM, Krol ADG, Nijziel MR, Zijlstra JM, van der Maazen RWM, Roesink JM, Jacobse JN, Schaapveld M, Schmidt MK, Opstal-van Winden AWJ, Sonke GS, Russell NS, Aleman BMP, van Leeuwen FE. Krul IM, et al. Among authors: nijziel mr. Cancer. 2022 Dec 15;128(24):4285-4295. doi: 10.1002/cncr.34464. Epub 2022 Oct 25. Cancer. 2022. PMID: 36281718 Free article.

7

Risk of male breast cancer after Hodgkin lymphoma.

de Vries S, Krul IM, Schaapveld M, Janus CPM, Rademakers SE, Roesink JM, Nijziel MR, Bilgin YM, Aleman BMP, van Leeuwen FE. de Vries S, et al. Among authors: nijziel mr. Blood. 2023 Aug 31;142(9):806-811. doi: 10.1182/blood.2023020940. Blood. 2023. PMID: 37390297

8

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.

Neppelenbroek SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, Rademakers SE, de Weijer RJ, Schippers MGA, Ta BDP, Plattel WJ, Zijlstra JM, van der Maazen RWM, Nijziel MR, Ong F, Schimmel EC, Posthuma EFM, Kersten MJ, Böhmer LH, Muller K, Koene HR, Te Boome LCJ, Bilgin YM, de Jongh E, Janus CPM, van Leeuwen FE, Schaapveld M. Neppelenbroek SIM, et al. Among authors: nijziel mr. J Clin Oncol. 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386. Online ahead of print. J Clin Oncol. 2024. PMID: 38359378

9

Long-term follow-up after cancer rehabilitation using high-intensity resistance training: persistent improvement of physical performance and quality of life.

De Backer IC, Vreugdenhil G, Nijziel MR, Kester AD, van Breda E, Schep G. De Backer IC, et al. Among authors: nijziel mr. Br J Cancer. 2008 Jul 8;99(1):30-6. doi: 10.1038/sj.bjc.6604433. Epub 2008 Jun 24. Br J Cancer. 2008. PMID: 18577993 Free PMC article. Clinical Trial.

10

The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.

Oerlemans S, Mols F, Nijziel MR, Lybeert M, van de Poll-Franse LV. Oerlemans S, et al. Among authors: nijziel mr. Ann Hematol. 2011 Sep;90(9):993-1004. doi: 10.1007/s00277-011-1274-4. Epub 2011 Jun 14. Ann Hematol. 2011. PMID: 21670973 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page